Y's Therapeutics
Stage
Other Investors | AliveAbout Y's Therapeutics
Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. The company also have small molecule compounds in the company's R&D pipeline to diversify the company's portfolio.
Missing: Y's Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Y's Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Y's Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Y's Therapeutics is included in 1 Expert Collection, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Y's Therapeutics Patents
Y's Therapeutics has filed 1 patent.
The 3 most popular patent topics include:
- Alternative cancer treatments
- Cancer treatments
- Experimental cancer drugs
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/14/2018 | Pseudoscience, Alternative cancer treatments, Experimental cancer drugs, Cancer treatments, Peripheral nervous system disorders | Application |
Application Date | 5/14/2018 |
|---|---|
Grant Date | |
Title | |
Related Topics | Pseudoscience, Alternative cancer treatments, Experimental cancer drugs, Cancer treatments, Peripheral nervous system disorders |
Status | Application |
Y's Therapeutics Frequently Asked Questions (FAQ)
Where is Y's Therapeutics's headquarters?
Y's Therapeutics's headquarters is located at 1111 Bayhill Drive, San Bruno.
What is Y's Therapeutics's latest funding round?
Y's Therapeutics's latest funding round is Other Investors.
Who are the investors of Y's Therapeutics?
Investors of Y's Therapeutics include Mitsubishi UFJ Capital.
Who are Y's Therapeutics's competitors?
Competitors of Y's Therapeutics include Humanetics, Symphogen, Altor BioScience, GANYMED Pharmaceuticals, Icagen (acquired by XRpro Sciences), Auspex Pharmaceuticals, Fibrotech Therapeutics, GlycoMimetics, Aragon Pharmaceuticals, Micromet and 28 more.
Compare Y's Therapeutics to Competitors
PharmAthene's primary objective is the development of effective countermeasures to a range of biological and chemical threats having potential lethal effects for the military or civilian populations. The Company is developing Valortim, an anthrax monoclonal antibody, in collaboration with Medarex, Inc. for pre- and post exposure prophylaxis and treatment, as well as Protexia, a recombinant human butyrylcholinesterase for treatment following exposure to chemical nerve agents.
Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.
Velbionanotech is designing drugs for various diseases such as Heart Disease, kidney stones, AIDS, Cancer, cosmetic generic products using a short fragment of DNA as a new type of drugs. These drugs are assembled in Nanochips and as nano particals for delivering in human body, which are affective in curing the sick/diseased and healing the injured. nVBN are working into New gene therapy procedures, DNA-based sensors, and other medical applications by using a new method developed to initiate and control chemical reactions on DNA strands. On the other hand silicon-based nanochips with itching and self-assembling techniques used to deliver drugs on the diseased molecules. The company are designing bionano products for the treatment of various diseases for Kidney stones,Gallbladder,Liver, Lungs,Heart etc mixing biology with traditional machinery. VBN Nanomedicine prepared for Heart disease, Galbladder, Liver, Kidney stones will have no side effect and it is safe to use since it is herbal. nn
ModiQuest (CRO) focus is on generation of recombinant monoclonal antibodies (animal, human). The company use antigen specific B-cell selection combined with efficient hybridoma generation or direct antibody cDNA cloning from selected B-cells. MQR offers custom phage display services.
Which is using a platform-technology approach to develop antibody and peptide-based therapeutics against select targets.
Oxford BioTherapeuticsis focused on the targeted treatment of cancer.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.